Kamu erişimi zorunlu olan makaleler - Michael A MendallDaha fazla bilgi edinin
Bir yerde sunuluyor: 7
The UK‐PBC risk scores: derivation and validation of a scoring system for long‐term prediction of end‐stage liver disease in primary biliary cholangitis
M Carbone, SJ Sharp, S Flack, D Paximadas, K Spiess, C Adgey, ...
Hepatology 63 (3), 930-950, 2016
Zorunlu olanlar: UK Medical Research Council, National Institute for Health Research, UK …
Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial
JAZ Jankowski, J De Caestecker, SB Love, G Reilly, P Watson, S Sanders, ...
The Lancet 392 (10145), 400-408, 2018
Zorunlu olanlar: Cancer Research UK, UK Medical Research Council, National Institute for …
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score
M Carbone, A Nardi, S Flack, G Carpino, N Varvaropoulou, C Gavrila, ...
The Lancet Gastroenterology & Hepatology 3 (9), 626-634, 2018
Zorunlu olanlar: UK Medical Research Council, National Institute for Health Research, UK …
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs
HJ Cordell, JJ Fryett, K Ueno, R Darlay, Y Aiba, Y Hitomi, M Kawashima, ...
Journal of hepatology 75 (3), 572-581, 2021
Zorunlu olanlar: US National Institutes of Health, Canadian Institutes of Health Research, UK …
X chromosome contribution to the genetic architecture of primary biliary cholangitis
R Asselta, EM Paraboschi, A Gerussi, HJ Cordell, GF Mells, RN Sandford, ...
Gastroenterology 160 (7), 2483-2495. e26, 2021
Zorunlu olanlar: US National Institutes of Health, National Natural Science Foundation of …
Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study
S Sebastian, GJ Walker, NA Kennedy, TE Conley, KV Patel, ...
The Lancet Gastroenterology & Hepatology 6 (4), 271-281, 2021
Zorunlu olanlar: UK Medical Research Council, National Institute for Health Research, UK
Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID‐19 pandemic: the PREPARE‐IBD multicentre cohort study
A Saifuddin, AJ Kent, SJ Mehta, LC Hicks, HA Gonzalez, JP Segal, ...
Alimentary Pharmacology & Therapeutics 56 (10), 1460-1474, 2022
Zorunlu olanlar: National Institute for Health Research, UK
Yayıncılık ve maddi kaynak bilgileri otomatik olarak bir bilgisayar programı tarafından belirlenmektedir